AG
RYTM icon

Advisor Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Advisor Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5K Hold
200
– – ﹤0.01% 4683
2019
Q3 		$4K Hold
200
– – ﹤0.01% 4775
2019
Q2 		$4K Hold
200
– – ﹤0.01% 4782
2019
Q1 		$5K Buy
+200
New +$5.75K ﹤0.01% 4703

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Advisor Group's RYTM Position: Q4 2019 in Review

Advisor Group held its Rhythm Pharmaceuticals (RYTM) position steady in Q4 2019 at 200 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4683.

Advisor Group first reported a position in RYTM in Q1 2019 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold RYTM as of Q4 2019.

  • Advisor Group held 200 shares of Rhythm Pharmaceuticals worth $5K as of Q4 2019.
  • Advisor Group left its Rhythm Pharmaceuticals share count unchanged in Q4 2019.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4683 holding.
  • Advisor Group first reported a position in Rhythm Pharmaceuticals in Q1 2019 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.